Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Peripheral blood plasma proteomics reveals dysregulated cholesterol transport and complement pathways in myeloproliferative neoplasms

Max Petersen, Anna Chorzalska, John Reagan, Nagib Ahsan, James He, Michael Clarke, Omonike Oyelola, Stephen Donnelly, Rabin Niroula, Thomas Ollila, Orly Leiva, Gabriela Hobbs, Patrycja Dubielecka

Blood (2025) 146 (Supplement 1): 3245.

https://doi.org/10.1182/blood-2025-3245

Published: 2025

Journal Articles

Decreased serum total cholesterol is associated with worse outcomes among patients with myeloproliferative neoplasms

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Michelle Lee, Chi-Joan How, Max Petersen, Patrycja Dubielecka, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 2020.

https://doi.org/10.1182/blood-2025-2020

Published: 2025

Journal Articles

Ruxolitinib and cardiovascular outcomes among patients with myelofibrosis

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2025-3796

Published: 2025

Journal Articles

Evaluating real-world diagnostic and treatment patterns, risk of thromboembolic events, and mortality for polycythemia vera across an integrated academic-community cancer network

Jessica Nino De Rivera, Orly Leiva, Vasileios Efthymiou, Odette Iskandar, Jessica Freydman, Gabriela Hobbs, Michelle Lee

Blood (2025) 146 (Supplement 1): 6390.

https://doi.org/10.1182/blood-2025-6390

Published: 2025

Journal Articles

Pulmonary hypertension on right heart catheterization is associated with worse progression-free survival in patients with myeloproliferative neoplasms

Orly Leiva, Olivia Liu, Victor You, Steven Soo, Justin Kahla, Yasmeen Murtaza, Andrew Palmer, Anand Patel, Olatoyosi Odenike, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5583.

https://doi.org/10.1182/blood-2025-5583

Published: 2025

Journal Articles

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Max Petersen, Patrycja Dubielecka, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5571.

https://doi.org/10.1182/blood-2025-5571

Published: 2025

Journal Articles

Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms

Orly Leiva, Steven Soo, Nathaniel Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Chi-Joan How, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 3188.

https://doi.org/10.1182/blood-2024-207586

Published: 2024

Journal Articles

Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms and Predictors of Hematologic Progression

Orly Leiva, Steven Soo, Nathaniel Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Chi-Joan How, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 246.

https://doi.org/10.1182/blood-2024-199120

Published: 2024

Journal Articles

Multicenter Retrospective Analysis of Eosinophilic Myeloid Neoplasms

Blood (2023) 142 (Supplement 1): 4576.

https://doi.org/10.1182/blood-2023-187092

Published: 2023

Journal Articles

Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases

Emily Abdelmessih, Stephanie Wo, David L. Green, Orly Leiva, Elaine Xiang, Tania Ahuja

Blood (2023) 142 (Supplement 1): 5122.

https://doi.org/10.1182/blood-2023-187523

Published: 2023

Journal Articles

Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease

Orly Leiva, Andrew M. Brunner, Joan How, Gabriela S. Hobbs, Jeffrey S Berger

Blood (2023) 142 (Supplement 1): 4570.

https://doi.org/10.1182/blood-2023-180783

Published: 2023

Journal Articles

Cardiovascular Risk Factors Are Common in Myeloproliferative Neoplasms and Portend Worse Survival and Thrombotic Outcomes

Joan How, Orly Leiva, Anna E. Marneth, Baransel Kamaz, Chulwoo J. Kim, Lachelle D. Weeks, Mohammed Wazir, Maximilian Stahl, Daniel J. DeAngelo, R. Coleman Lindsley, Marlise R. Luskin, Gabriela S. Hobbs

Blood (2023) 142 (Supplement 1): 4568.

https://doi.org/10.1182/blood-2023-179324

Published: 2023

Journal Articles

Myelofibrosis Is Associated with Poor Cardiovascular Outcomes after Heart Failure Hospitalization

Orly Leiva, Jose Alvarez-Cardona, Andrew M. Brunner, Chi-Joan How, Gabriela S. Hobbs

Blood (2023) 142 (Supplement 1): 3203.

https://doi.org/10.1182/blood-2023-173589

Published: 2023

Journal Articles

Outcomes of Catheter-Based Therapy for Cancer-Associated Intermediate or High-Risk Pulmonary Embolism

Orly Leiva, Eric H Yang, Rachel P. Rosovsky, Carlos Alviar, Sripal Bangalore

Blood (2023) 142 (Supplement 1): 2361.

https://doi.org/10.1182/blood-2023-187947

Published: 2023

Journal Articles

Risk Factors for Major Adverse Cardiac Events and Bleeding in Patients with Myeloproliferative Neoplasms Admitted for Myocardial Infarction

Orly Leiva, Emaad Siddiqui, Gabriela S. Hobbs, Sripal Bangalore

Blood (2022) 140 (Supplement 1): 9729–9730.

https://doi.org/10.1182/blood-2022-157476

Published: 2022

Journal Articles

Trends in All-Cause and Cardiovascular Mortality Among Patients with Myeloproliferative Neoplasms: A Surveillance, Epidemiology, and End Results Database Analysis

Orly Leiva, Chi-Joan How, Andrew M. Brunner, Gabriela S. Hobbs

Blood (2022) 140 (Supplement 1): 6808–6809.

https://doi.org/10.1182/blood-2022-170607

Published: 2022

Journal Articles

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19

Orly Leiva, Umberto Campia, Julia Snyder, Briana Barns, Samantha Rizzo, Candrika Khairani, Hanny Al-Samkari, Rebecca Karp Leaf, Rachel P. Rosovsky, Katayoon Goodarzi, Amir T. Fathi, Samuel Z. Goldhaber, Gregory Piazza, Gabriela Hobbs

Blood (2021) 138 (Supplement 1): 1508.

https://doi.org/10.1182/blood-2021-151801

Published: 2021

Journal Articles

Pulmonary Hypertension Is Associated with Poor Outcomes in Patients with Myeloproliferative Neoplasms and Cardiovascular Disease

Orly Leiva, Siyang Ren, Donna S. Neuberg, Ankeet Bhatt, Andrew Jenkins, Rachel P. Rosovsky, Rebecca Karp Leaf, Katayoon Goodarzi, Gabriela Hobbs

Blood (2021) 138 (Supplement 1): 3653.

https://doi.org/10.1182/blood-2021-149799

Published: 2021

Journal Articles

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Orly Leiva, MD, Olesya Baker, PhD, Andrew M. Brunner, Hanny Al-Samkari, MD, Rebecca Karp Leaf, MD, Rachel P. Rosovsky, MD MPH, Amir T. Fathi, MD, James I Weitzman, MD, Larissa Bornikova, MD, Valentina Nardi, MD, Gabriela S. Hobbs, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-137311

Published: 2020

Journal Articles

Integrin-Mediated Adhesion to Extracellular Matrix Protein Fibronectin Drives Megakaryocytosis in JAK2 V617F+ Primary Myelofibrosis

Shinobu Matsuura, DVM,PhD, Cristal Reyna Thompson, PhD, Seng Kah Ng, PhD, Aikaterini Karagianni, MSc, Christina Ward Torres, PhD, Carla Silvana Mazzeo, PhD, Orly Leiva, MD, Alessandro Malara, PhD, Alessandra Balduini, MD, Katya Ravid, PhD DSc

Blood (2019) 134 (Supplement_1): 4205.

https://doi.org/10.1182/blood-2019-132124

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Peripheral blood plasma proteomics reveals dysregulated cholesterol transport and complement pathways in myeloproliferative neoplasms

Decreased serum total cholesterol is associated with worse outcomes among patients with myeloproliferative neoplasms

Ruxolitinib and cardiovascular outcomes among patients with myelofibrosis

Evaluating real-world diagnostic and treatment patterns, risk of thromboembolic events, and mortality for polycythemia vera across an integrated academic-community cancer network

Pulmonary hypertension on right heart catheterization is associated with worse progression-free survival in patients with myeloproliferative neoplasms

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms

Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms

Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms and Predictors of Hematologic Progression

Multicenter Retrospective Analysis of Eosinophilic Myeloid Neoplasms

Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases

Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease

Cardiovascular Risk Factors Are Common in Myeloproliferative Neoplasms and Portend Worse Survival and Thrombotic Outcomes

Myelofibrosis Is Associated with Poor Cardiovascular Outcomes after Heart Failure Hospitalization

Outcomes of Catheter-Based Therapy for Cancer-Associated Intermediate or High-Risk Pulmonary Embolism

Risk Factors for Major Adverse Cardiac Events and Bleeding in Patients with Myeloproliferative Neoplasms Admitted for Myocardial Infarction

Trends in All-Cause and Cardiovascular Mortality Among Patients with Myeloproliferative Neoplasms: A Surveillance, Epidemiology, and End Results Database Analysis

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19

Pulmonary Hypertension Is Associated with Poor Outcomes in Patients with Myeloproliferative Neoplasms and Cardiovascular Disease

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Integrin-Mediated Adhesion to Extracellular Matrix Protein Fibronectin Drives Megakaryocytosis in JAK2 V617F+ Primary Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only